Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

525.70 8.07 −1.51%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

23.19 20.54 23.37 24.10
P/S ratio
2.43 2.03 2.36 2.48
P/FCF ratio
18.67 13.53 18.70 22.22
P/Operating CF
46.13 58.55 72.34 116.54
P/B ratio
6.29 6.09 7.39 7.66
EV/Sales
2.45 2.06 2.40 2.55
EV/EBITDA
15.34 13.31 15.00 15.47
EV/FCF
18.75 13.74 19.02 22.87
Current Ratio
1.05 0.85 0.91 1.11
Net Debt/EBITDA
(0.64) 0.73 0.94 1.65
Debt/Equity
0.00 0.11 0.17 0.27
Earnings Yield
4.31% 4.87% 4.28% 4.15%
Free Cash Flow Yield
5.36% 7.39% 5.35% 4.50%
Free Cash Flow per Share
8.20 5.21 5.28 2.91
Book value per Share
68.02 62.01 63.04 65.97
Free Cash Flow
118.00 71.24 69.58 37.94
EV/EBIT
18.30 15.99 17.87 18.30
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026